Clinical trial
Maintenance Gemcitabine in the Chinese Advanced Lung Cancer
NCT01336192
Study timeline
Study start (unknown)2011-04-01Date precision: month
Registry last updated2011-04-15
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Cancerunresolved
Interventions
GemcitabineDRUG · verified · RxNorm: gemcitabine
Sponsors & collaborators
Tongji Universitylead sponsor
Shanghai Pulmonary Hospital, Shanghai, Chinacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01336192 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.